Dr. Anurag Gupta is a distinguished medical professional with extensive expertise in Molecular Oncopathology, Cytogenetics of Leukemia’s, Lymphomas, and Solid Malignancies. He currently serves as the Director of Genomics at Tapadia Diagnostics and the Chief Executive Officer of Kanopy Diagnostics, where he spearheads innovation and advanced diagnostic practices in genomic medicine. Dr. Gupta’s work bridges clinical medicine, molecular research, and healthcare leadership. His expertise lies in deploying molecular oncopathology and cytogenetic insights to enable early cancer detection, optimize treatment pathways, and improve patient outcomes. He is also a NABL Assessor and a National Subcommittee Member – NABL Genomics, contributing to the updated version of NABL 112 guidelines. A prolific academic contributor, Dr. Gupta has authored multiple publications in reputed national and international journals and actively serves as a reviewer for leading Indian and international scientific journals. His commitment to advancing genomic science and diagnostic excellence has positioned him as a key thought leader in the field. As both a clinician and an administrator, he combines medical precision with organizational strategy, ensuring that diagnostics are not only scientifically advanced but also accessible and patient-centered.